Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Genprex, Inc.GNPX · Entity 8441 | Chief Mfgr & Tech Officer | February 18, 2023 | February 22, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Genprex, Inc.
Report date February 18, 2023 · Filed February 22, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 200,000 |
Reported balance
After 2023-02-18 transaction · row 1
1 source rowRow 1 · 2023-02-18 · Grant · Acquired 200,000 · Balance 200,000 F1: This award of Restricted Stock Units ("RSUs") is granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan and vests in installments of 50% on the first anniversary of the date of grant and the remaining 50% on the second anniversary of the date of grant. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: This award of Restricted Stock Units ("RSUs") is granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan and vests in installments of 50% on the first anniversary of the date of grant and the remaining 50% on the second anniversary of the date of grant. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2023 Filed Feb 22, 2023 23:28 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004239 · rdgdoc.xml · nonDerivative · entry 1 Kumar Hermant · CIK 0001884546 · Chief Mfgr & Tech Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 F1 · shares: This award of Restricted Stock Units ("RSUs") is granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan and vests in installments of 50% on the first anniversary of the date of grant and the remaining 50% on the second anniversary of the date of grant. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 20:45 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001437749-22-016003 · rdgdoc.xml · derivative · entry 1 Kumar Hermant · CIK 0001884546 · Chief Mfgr & Tech Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-06-23 F1 · derivative.exercise_date: One third (1/3) of the Shares subject to the Option shall vest on each annual anniversary of June 23, 2022 so that one hundred percent (100%) of the shares subject to the Option are vested on the third anniversary of June 23, 2022 provided that the optionee continues to serve as a Service Provider (as defined in Genprex, Inc. 2018 Equity Incentive Plan) through the applicable vesting date. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 21:29 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantStock Option (right to buy) · Derivative | 54,312 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001437749-22-002742 · rdgdoc.xml · derivative · entry 1 Kumar Hermant · CIK 0001884546 · Chief Mfgr & Tech Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,312 Underlying: Common Stock · 54,312 shares Expires 2032-02-04 F1 · derivative.exercise_date: The option (the "Option") was granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan (the "Plan"). The Option shall vest and become exercisable as to one third (1/3) of the total number of shares (the "Shares") of the Company's common stock, $.001 par value subject to the Option on February 4, 2023 (the "Vesting Commencement Date") and thereafter shall vest and become exercisable as to an additional 1/24 of the remaining Shares subject to the Option on each monthly anniversary of the Vesting Commencement Date until fully vested and exercisable, in each case provided that the Optionee continues to serve as a Service Provider (as defined in the Plan) through the applicable vesting date. Read SEC document |
| September 27, 2021 Filed Sep 28, 2021 20:28 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001437749-21-022778 · rdgdoc.xml · derivative · entry 1 Kumar Hermant · CIK 0001884546 · Chief Mfgr & Tech Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2031-09-27 F1 · security: The options were granted outside of the Registrant's incentive award plans as an inducement grant pursuant to Nasdaq Listing Rule 5635(c)(4). F2 · derivative.exercise_date: One-third of the options will vest on each of the first, second and third anniversaries of the date on which the Reporting Person commences employment with the Registrant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.